TEMPERO PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, September 24, 2009, a trademark application was filed for TEMPERO PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the TEMPERO PHARMACEUTICALS trademark a serial number of 77834340. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 12, 2018. This trademark is owned by Glaxo Group Limited. The TEMPERO PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceuticals targeting T-cells and autoimmune diseases; medical and scientific research, namely, conducting clinical trials relating to pharmaceuticals for treatment of autoimmune diseases; scientific consulting in the field of pharmaceutical products targeting autoimmune diseases, providing information in the area of laboratory technology relating to autoimmune diseases; medical laboratory services relating to autoimmune diseases; providing scientific information in the field of pharmaceuticals targeting autoimmune diseases via Internet website portals
tempero pharmaceuticals

General Information

Serial Number77834340
Word MarkTEMPERO PHARMACEUTICALS
Filing DateThursday, September 24, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 12, 2018
Registration Number3975264
Registration DateTuesday, June 7, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2010

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesResearch and development services in the field of pharmaceuticals targeting T-cells and autoimmune diseases; medical and scientific research, namely, conducting clinical trials relating to pharmaceuticals for treatment of autoimmune diseases; scientific consulting in the field of pharmaceutical products targeting autoimmune diseases, providing information in the area of laboratory technology relating to autoimmune diseases; medical laboratory services relating to autoimmune diseases; providing scientific information in the field of pharmaceuticals targeting autoimmune diseases via Internet website portals
Translation of Words in MarkThe English translation of "TEMPERO" in the mark is "SEASONABLENESS".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 12, 2018
Primary Code042
First Use Anywhere DateWednesday, March 31, 2010
First Use In Commerce DateWednesday, March 31, 2010

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, January 12, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, June 7, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 30, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 29, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 21, 2011USE AMENDMENT FILED
Monday, April 25, 2011EXTENSION 1 GRANTED
Thursday, April 21, 2011EXTENSION 1 FILED
Monday, April 25, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 21, 2011TEAS EXTENSION RECEIVED
Thursday, April 21, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, November 23, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2010PUBLISHED FOR OPPOSITION
Wednesday, August 25, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 25, 2010ASSIGNED TO LIE
Sunday, August 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 15, 2010EXAMINER'S AMENDMENT ENTERED
Thursday, July 15, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 15, 2010EXAMINERS AMENDMENT E-MAILED
Thursday, July 15, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 23, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 24, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 24, 2009NON-FINAL ACTION E-MAILED
Thursday, December 24, 2009NON-FINAL ACTION WRITTEN
Thursday, December 24, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 24, 2009NON-FINAL ACTION E-MAILED
Thursday, December 24, 2009NON-FINAL ACTION WRITTEN
Monday, December 21, 2009ASSIGNED TO EXAMINER
Friday, November 6, 2009TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, November 6, 2009TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 29, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 28, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals tempero autoimmune diseases scientific relating targeting field providing laboratory information